Search research articles
Contact Us
Filters
Showing results (111-120 of 179) with videos related to
Page
of 18
Sort By:
Journal of Neuro-Oncology
|
December 14, 2017
Outcome of children and adolescents with central nervous system tumors in phase I trials
Fernando Carceller, Francisco Bautista, Irene Jiménez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 19, 2010
Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours
Hervé Rubie, Birgit Geoerger, Didier Frappaz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 25, 2017
Open-label, multicentre, randomised, phase II study of the EpSSG and the ITCC evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients with metastatic soft tissue sarcoma (the BERNIE study)
Julia C Chisholm, Johannes H M Merks, Michela Casanova, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 2016
Prognostic factors of overall survival in children and adolescents enrolled in dose-finding trials in Europe: An Innovative Therapies for Children with Cancer study
Fernando Carceller, Francisco J Bautista, Irene Jiménez, et al.
Neuro-Oncology
|
June 13, 2017
Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma
Mark W Kieran, Julia Chisholm, Michela Casanova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2017
A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors
Birgit Geoerger, Franck Bourdeaut, Steven G DuBois, et al.
Neuro-Oncology
|
October 27, 2010
Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors
Birgit Geoerger, Darren Hargrave, Fabienne Thomas, et al.
Journal of Internal Medicine
|
August 29, 2023
Precision cancer medicine: Concepts, current practice, and future developments
Anders Edsjö, Louise Holmquist, Birgit Geoerger, et al.
Cancers
|
July 14, 2023
Cell-Free DNA Extracted from CSF for the Molecular Diagnosis of Pediatric Embryonal Brain Tumors
Mathieu Chicard, Yasmine Iddir, Julien Masliah Planchon, et al.
Blood
|
October 17, 2021
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma
Elif Karaca Atabay, Carmen Mecca, Qi Wang, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 179) with videos related to
Sort By:
Page
of 18
Journal of Neuro-Oncology
|
December 14, 2017
Outcome of children and adolescents with central nervous system tumors in phase I trials
Fernando Carceller, Francisco Bautista, Irene Jiménez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 19, 2010
Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours
Hervé Rubie, Birgit Geoerger, Didier Frappaz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 25, 2017
Open-label, multicentre, randomised, phase II study of the EpSSG and the ITCC evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients with metastatic soft tissue sarcoma (the BERNIE study)
Julia C Chisholm, Johannes H M Merks, Michela Casanova, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 2016
Prognostic factors of overall survival in children and adolescents enrolled in dose-finding trials in Europe: An Innovative Therapies for Children with Cancer study
Fernando Carceller, Francisco J Bautista, Irene Jiménez, et al.
Neuro-Oncology
|
June 13, 2017
Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma
Mark W Kieran, Julia Chisholm, Michela Casanova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2017
A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors
Birgit Geoerger, Franck Bourdeaut, Steven G DuBois, et al.
Neuro-Oncology
|
October 27, 2010
Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors
Birgit Geoerger, Darren Hargrave, Fabienne Thomas, et al.
Journal of Internal Medicine
|
August 29, 2023
Precision cancer medicine: Concepts, current practice, and future developments
Anders Edsjö, Louise Holmquist, Birgit Geoerger, et al.
Cancers
|
July 14, 2023
Cell-Free DNA Extracted from CSF for the Molecular Diagnosis of Pediatric Embryonal Brain Tumors
Mathieu Chicard, Yasmine Iddir, Julien Masliah Planchon, et al.
Blood
|
October 17, 2021
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma
Elif Karaca Atabay, Carmen Mecca, Qi Wang, et al.
Page
of 18